Eam Investors, LLC Ardelyx, Inc. Transaction History

Eam Investors, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Jul 12, 2023	BUY	$2.68 - $4.79 $1.76 Million - $3.15 Million	656,626 Added 2242.8%	685,903 $3.29 Million
Q1 2023 May 12, 2023	SELL	$2.68 - $4.79 $1.86 Million - $3.32 Million	-692,321 Reduced 95.94%	29,277 $140,000
Q4 2022 Feb 14, 2023	BUY	$1.22 - $2.85 $880,349 - $2.06 Million	721,598 New	721,598 $2.06 Million
Q3 2020 Nov 13, 2020	SELL	$5.25 - $7.08 $418,965 - $565,005	-79,803 Closed	0 $0
Q2 2020 Aug 13, 2020	SELL	$5.37 - $8.11 $1.78 Million - $2.68 Million	-330,931 Reduced 80.57%	79,803 $552,000
Q1 2020 May 13, 2020	BUY	$4.35 - $8.79 $167,740 - $338,951	38,561 Added 10.36%	410,734 $2.34 Million
Q4 2019 Feb 11, 2020	BUY	$4.23 - $8.29 $63,834 - $125,104	15,091 Added 4.23%	372,173 $2.79 Million
Q3 2019 Nov 13, 2019	BUY	$2.15 - $6.28 $767,726 - $2.24 Million	357,082 New	357,082 $1.68 Million

219

141M

1.08M

Ticker ARDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 154,636,000
Market Cap $815M
Description
Ardelyx, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the United States and internationally. The company's lead product candidate is tenapanor, which has completed Phase III clinical trial for the treatment of patients with irritable bowel synd...

Get notified when there are updates to the investment portfolio of Eam Investors, LLC, based on Form 13F filings with the SEC.

Stay updated on Eam Investors, LLC with notifications on news.